ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Gerontology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 21

$239K Total Retail Price of All Prescriptions

Rank: 2 out of 21

194 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 4,233 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 249 241 1 4
AMLODIPINE BESYLATE 205 192 2 2
OMEPRAZOLE 203 192 3 10
TRAMADOL HCL 147 129 4 19
DONEPEZIL HCL 141 141 5 20
FUROSEMIDE 136 130 6 1
METOPROLOL TARTRATE 135 128 7 7
TRAZODONE HCL 125 125 8 14
NAMENDA 120 120 9 33
SEROQUEL 106 106 10 35
LEVOTHYROXINE SODIUM 97 93 11 5
RANITIDINE HCL 94 94 12 37
LISINOPRIL 89 87 13 3
HYDROCHLOROTHIAZIDE 88 84 14 15
MIRTAZAPINE 86 86 15 31
CITALOPRAM HBR 83 78 16 26
RISPERIDONE 78 78 17 43
GABAPENTIN 77 68 18 12
GLIPIZIDE 75 69 19 45
QUETIAPINE FUMARATE 71 61 20 48
PRAVASTATIN SODIUM 64 59 21 16
POTASSIUM CHLORIDE 58 58 22 18
METFORMIN HCL 57 49 23 28
DIVALPROEX SODIUM 56 51 24 57
ALENDRONATE SODIUM 53 53 25 27
LIDODERM 50 41 26 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.